MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra...

Halozyme reports better-than-expected third-quarter 2024 results. The company raises revenue guidance for 2024. Stock rises in after-hours trading.

Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales. Management raises...

CORT beats on both earnings and sales in the third quarter of 2024. The company increases the revenue guidance for 2024. Stock falls in after-hours...

PFE beats third-quarter estimates for earnings and sales. It raises 2024 earnings and revenue expectations.

GNRC's third-quarter results gain from strengthening Residential product sales. Management raises sales outlook for 2024 due to higher power outage...

VTRS Q3 earnings and sales beat estimates. New products perform well.

FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.

KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek's launch in the United States shows strong uptake.

BMY posts impressive third-quarter results, with both earnings and sales beating the respective estimates. The company also raises its annual earnings...